Navigation Links
ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer
Date:11/24/2008

elp patients diagnosed with this disease.

About Pancreatic Cancer

The pancreas is a gland deep in the abdomen, behind the stomach, that is part of the digestive and endocrine systems. The pancreas makes juices that help with digestion (enzymes) as well as important hormones such as insulin that control the level of sugar in the bloodstream. Pancreatic cancer is difficult to diagnose early, as the symptoms are often minor or non-existent until the tumor has extended outside the pancreas. Once outside the pancreas, the tumor invades a number of adjacent organs and is usually not amenable to surgical resection. There are no reliable early diagnostic tests for pancreatic cancer.

Scientific research is in the basic stages. Advancing pancreatic cancer research into the 21st century is dependent upon the increase of basic science research. Pancreatic cancer risk factors need to be identified and verified before research about prevention methods can begin. Recent research studies indicate that approximately 10 percent of pancreatic cancer cases are familial and another 30 percent are thought to result from cigarette smoking. Some other risk factors scientists are currently studying include: diabetes, chronic and hereditary pancreatitis (inflammation of the pancreas), obesity, physical activity, and diet.

"Screening for pancreatic cancer in relatives of affected people is not often done in the United States," said Pochapin. "However, families with many cases of pancreatic cancer or close relatives of people who developed pancreatic cancer at an early age should seek the advice of a specialist such as a gastroenterologist or oncologist, as there are specific genetic syndromes that may increase susceptibility for pancreatic cancer."

Symptoms and Detection

Since the pancreas is near the drainage tubes for bile and digestive enzymes, a mass in the pancreas can b
'/>"/>

SOURCE American Society for Gastrointestinal Endoscopy
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Tapestry Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer
2. EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer
3. Mayo Clinic Study Finds Further Association Between Diabetes and Pancreatic Cancer
4. Raven Announces Initiation of a RAV12 Phase 2 Clinical Trial in Metastatic Pancreatic Cancer
5. Repligen Initiates Phase 3 Clinical Trial of RG1068 for Pancreatic MRI Imaging
6. Senescos Preclinical Pancreatic Islet Data to be Presented at Upcoming Conferences
7. Senesco Expands on Recently Announced Preclinical Pancreatic Islet Data
8. Repligen Receives FDA Fast Track Designation for RG1068 for Pancreatic Imaging
9. Interim Analysis of Phase I/II Study of Rexin-G Confirms Efficacy With No Dose Limiting Toxicity in Metastatic Pancreatic Cancer
10. Patients with Pancreatic Cancer Can Benefit From Avastin(R) Plus Tarceva(R)
11. Anti-TGF-Beta Antisense AP 12009 Shows Very Good Safety and Tolerability in Systemic Treatment of Pancreatic Carcinoma, Malignant Melanoma and Colorectal Carcinoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... International Inc. (NYSE: MTD ) today announced second ... , Sales in local currency increased 3% ... sales decreased 4% as currency reduced sales growth by ... diluted share as reported (EPS) were $2.73, compared with ... , an increase of 9% over the prior-year ...
(Date:7/30/2015)... SAN DIEGO , July 30, 2015 /PRNewswire/ ... a medical device company and manufacturer of the ... it has entered into non-exclusive Development Agreements with ... generation Tandem insulin pumps with the Dexcom G5 ... "Integrating Tandem,s next generation pump platform with ...
(Date:7/30/2015)... , July 30, 2015  OncoGenex Pharmaceuticals, Inc. ... report its second quarter 2015 financial results on Thursday, ... call and live webcast at 4:30 p.m. Eastern Time ... programs and a general corporate update. ... Relations page of the OncoGenex website at www.oncogenex.com ...
Breaking Medicine Technology:Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 2Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 3Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 4Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 5Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 6Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 7Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 8Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 9Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 10Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 11Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 12Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 13Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 14Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 2Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 3
... AXA Research Fund closed out its first year of existence. ... 13 million to various European research institutions.The purpose of the ... risks in the world by supporting cutting edge scientific research. ... million over five years, making it a major initiative in ...
... N.J., March 23 Each year in the United States ... myeloma. These new cases account for 10 percent of ... For several types of leukemia, the survival rate has ... James M. Golubieski, president of Foundation Venture Capital Group, LLC, ...
Cached Medicine Technology:First Year Results of the AXA Research Fund: Over Euro 13 Million Allocated for Research in 2008 2First Year Results of the AXA Research Fund: Over Euro 13 Million Allocated for Research in 2008 3Foundation Venture Capital Group Invests in UMDNJ Company Working to Improve Leukemia Treatments 2
(Date:7/31/2015)... ... July 31, 2015 , ... The 2015 New York ... family members, medical professionals, and researchers, covering a variety of topics related to ... collaborative effort between the Mesothelioma Applied Research Foundation and Memorial Sloan Kettering Cancer ...
(Date:7/31/2015)... , ... July 31, 2015 , ... ... research firm, has been recognized in the 2015 Aster Awards national competition for ... healthcare organization serving Ocean City and surrounding communities in Coastal Maryland and Southern ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... Northern District of Ohio, Western Division (Case No. 3:15-cv-00397) involving the Implanon® ... women experienced spontaneous migration of their Implanon® implants, inability to locate the implants, ...
(Date:7/31/2015)... ... July 31, 2015 , ... Burnaby sports physiotherapy clinic, ... the understanding and treatment of ankle sprains. A common sports injury, ankle sprains ... be dangerous if the condition augments and causes more disruption. Absolute PhysioCare’s blog ...
(Date:7/31/2015)... ... July 31, 2015 , ... Indosoft, Inc., is pleased to ... Q-Suite 5.9. Q-Suite is their flagship contact center ACD system for Asterisk-based call ... display logic shows the script components to the agent only when wanted, and allows ...
Breaking Medicine News(10 mins):Health News:New York Area Mesothelioma Specialists to Present at Conference 2Health News:New York Area Mesothelioma Specialists to Present at Conference 3Health News:Mullin/Ashley Associates Wins in the 2015 Aster Awards National Competition for Excellence in Medical Marketing 2Health News:Can Implanon® (Etonogestrel Implant) Go Missing? Zoll, Kranz & Borgess, LLC Files Another Lawsuit on Behalf of Women with Lost or Migrated Implanon® Implants 2Health News:Can Implanon® (Etonogestrel Implant) Go Missing? Zoll, Kranz & Borgess, LLC Files Another Lawsuit on Behalf of Women with Lost or Migrated Implanon® Implants 3Health News:Absolute PhysioCare & Sports Rehab Promotes Understanding & Treatment of Ankle Sprains 2Health News:Q-Suite 5.9 Adds Validation Tools to Call Center Software Agent Screen 2
... Reporter , THURSDAY, Sept. 9 (HealthDay News) -- In 2000, ... fruit and vegetables people should eat, but a decade later ... those thresholds, health officials said Thursday. In fact, according ... 2009, 67.5 percent of adults ate fruit less than two ...
... By Randy Dotinga HealthDay Reporter , THURSDAY, ... a quick MRI scan could tell doctors if a child,s ... that mental problems are developing. Researchers say the strategy ... to the age-old growth charts that tell pediatricians if kids ...
... This release is available in French . ... The Journal of Sexual Medicine has found that ... women,s chronic vulvovaginal pain may trigger more pain, but also ... took part in the study, conducted by the University of ...
... of the world,s population is infected with Mycobacterium tuberculosis ... of death world-wide. A new discovery, led by a ... of Medicine, offers hope for new approaches to the ... a novel mechanism that may contribute to immune recognition ...
... , THURSDAY, Sept. 9 (HealthDay News) -- A newly developed ... the kinds of medical problems that may face premature infants, ... a computational method to create a score based on factors ... the first three hours after birth. In a new study, ...
... A method that is widely used to predict the risk ... for millions of Americans, according to a study directed by ... the University of California, San Francisco. The method in ... which is used to estimate a patient,s 10-year risk of ...
Cached Medicine News:Health News:Most Americans Still Not Eating Enough Fruits, Veggies 2Health News:Most Americans Still Not Eating Enough Fruits, Veggies 3Health News:Brain Scans Could Spot Developmental Problems in Kids 2Health News:Romantic partner may play role in reducing vulvovaginal pain 2Health News:New dual recognition mechanism discovered in tuberculosis 2Health News:New dual recognition mechanism discovered in tuberculosis 3Health News:New Tool Aims to Predict Problems in Preemies 2Health News:Simplified heart-risk guideline may miscalculate risk for millions 2Health News:Simplified heart-risk guideline may miscalculate risk for millions 3
... Size: 3.0 x 7.5 x ... Scleral Sponge II line designed by ... material is a closed cell sponge ... are soft with rounded edges to ...
... x 80 mm. Storz offers the ... by Harvey A. Lincoff, M.D. ... sponge which is non-toxic and non-antigenic. ... to minimize scleral intrusion. These implants ...
Thin silicone pad implant. Indications: For closing scleral ruptures. Overall length: 7.8 mm....
... mm. Half oval. The original Scleral Sponge II ... been modified by Dr. Joseph Olk with this ... cell sponge which is non-toxic and non-antigenic. Implants ... intrusion. These implants are packaged sterile and sold ...
Medicine Products: